Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette–Guérin immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-019-02956-6.pdf
Reference20 articles.
1. Andius P, Damm O, Holmang S (2004) Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette–Guerin. Scand J Urol Nephrol 38:285–290
2. Babjuk M, Bohle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. https://doi.org/10.1016/j.eururo.2016.05.041
3. Cao D, Vollmer RT, Luly J, Jain S, Roytman TM, Ferris CW, Hudson MA (2010) Comparison of 2004 and 1973 world health organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 76:593–599. https://doi.org/10.1016/j.urology.2010.01.032
4. Chade DC, Shariat SF, Adamy A, Bochner BH, Donat SM, Herr HW, Dalbagni G (2010) Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol 184:464–469. https://doi.org/10.1016/j.juro.2010.03.134
5. Chan KS, Espinosa I, Chao M et al (2009) Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA 106:14016–14021. https://doi.org/10.1073/pnas.0906549106
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up;European Urology Focus;2023-03
2. Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: Lessons learned from long-term follow-up of a series of CIS patients treated with BCG;Urologic Oncology: Seminars and Original Investigations;2022-01
3. Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette–Guérin immunotherapy;BJU International;2021-08-23
4. Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy;Translational Andrology and Urology;2020-06
5. Carcinoma in situ of the bladder;Current Opinion in Urology;2020-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3